Stay updated on FLYSYN-101 Clinical Trial in MRD Positive AML

Sign up to get notified when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.
Latest website image capture
Clouds background image

Latest updates to the FLYSYN-101 Clinical Trial in MRD Positive AML page

  1. Check
    2 days ago
    Change Detected
    Summary
    A banner about NIH website updates and the transition from “Artificial Intelligence” to “Super Intelligence” is no longer displayed.
    Difference
    1%
    Check dated 2026-11-10T06:50:16.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-11-03T06:41:36.000Z thumbnail image
  3. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-20T08:28:42.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T10:20:20.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details view and blocking access to the record. This reflects an access restriction rather than a content update to the study information.
    Difference
    0.5%
    Check dated 2026-09-29T09:56:18.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details and navigation with an error page. Access to the study record is blocked at this URL.
    Difference
    18%
    Check dated 2026-09-22T12:41:37.000Z thumbnail image

Stay in the know with updates to FLYSYN-101 Clinical Trial in MRD Positive AML

Enter your email address, and we'll notify you when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.